Cargando…

Health-Related Quality of Life in Turner Syndrome and the Influence of Growth Hormone Therapy: A 20-Year Follow-Up

CONTEXT: The factors that affect the health-related quality of life (HRQoL) of women with Turner syndrome (TS) are controversial. OBJECTIVE: The aim was to describe the HRQoL of women with TS with a focus on how given GH treatment and comorbidity influence HRQoL in adulthood and to compare HRQoL of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krantz, Emily, Landin-Wilhelmsen, Kerstin, Trimpou, Penelope, Bryman, Inger, Wide, Ulla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760289/ https://www.ncbi.nlm.nih.gov/pubmed/31009056 http://dx.doi.org/10.1210/jc.2019-00340

Ejemplares similares

Comparison between different instruments for measuring health-related quality of life in a population sample, the WHO MONICA Project, Gothenburg, Sweden: an observational, cross-sectional study
por: Krantz, Emily, et al.
Publicado: (2019)

Side differences in the degree of mosaicism of the buccal mucosa in Turner syndrome
por: Thunström, Sofia, et al.
Publicado: (2019)

Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study
por: Kontogeorgos, Georgios, et al.
Publicado: (2022)

High androgen levels protect against hypothyroidism
por: Schmidt, Johanna, et al.
Publicado: (2016)

Low health-related quality of life in hypoparathyroidism and need for PTH analog
por: Kontogeorgos, Georgios, et al.
Publicado: (2021)

Comorbidity and quality of life in obesity–a comparative study with the general population in Gothenburg, Sweden
por: Mejaddam, Ala, et al.
Publicado: (2022)

Comorbidity and health-related quality of life in Somali women living in Sweden
por: Demeke, Taye, et al.
Publicado: (2019)

Normocalcaemic, vitamin D‐sufficient hyperparathyroidism – high prevalence and low morbidity in the general population: A long‐term follow‐up study, the WHO MONICA project, Gothenburg, Sweden
por: Kontogeorgos, Georgios, et al.
Publicado: (2015)

The complexity of fertility preservation for women with Turner syndrome and the potential risks of pregnancy and cardiovascular complications
por: Rodriguez‐Wallberg, Kenny A., et al.
Publicado: (2020)

Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls
por: Forslund, Maria, et al.
Publicado: (2018)

Hearing and Balance Exceed Initial Bone Mineral Density in Predicting Incident Fractures: A 25‐Year Prospective Observational Study in Menopausal Women With Osteoporosis
por: Dotevall, Annika, et al.
Publicado: (2021)

Iodine Status After Bariatric Surgery—a Prospective 10-Year Report from the Swedish Obese Subjects (SOS) Study
por: Manousou, Sofia, et al.
Publicado: (2017)

Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution
por: Forslund, M, et al.
Publicado: (2020)

Recombinant human growth hormone in the treatment of Turner syndrome
por: Spiliotis, Bessie E
Publicado: (2008)

Concomitant occurrence of Turner syndrome and growth hormone deficiency
por: Yu, Jung, et al.
Publicado: (2016)

Vitamin D-Binding Protein and the Free Hormone Hypothesis for Vitamin D in Bio-Naïve Patients with Psoriasis
por: Vandikas, Maria Siekkeri, et al.
Publicado: (2022)

Turner syndrome and growth hormone therapy: a review on growth response
por: Selveindran, Nalini M, et al.
Publicado: (2015)

Care of girls and women with Turner syndrome: beyond growth and hormones
por: Culen, Caroline, et al.
Publicado: (2017)

Coexisting Turner's syndrome, Hashimoto's thyroiditis, and growth hormone deficiency
por: Oueslati, Ibtissem, et al.
Publicado: (2016)

SAT-049 Growth Hormone Treatment in Mexican Turner's Syndrome
por: Bonilla, Paola, et al.
Publicado: (2019)

Craniofacial Morphology in Children with Growth Hormone Deficiency and Turner Syndrome
por: Wójcik, Dorota, et al.
Publicado: (2020)

Body proportions in patients with Turner syndrome on growth hormone treatment
por: KARDELEN, Aslı Derya, et al.
Publicado: (2022)

A Critical Appraisal of Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome Patients in Turkey
por: Yavaş Abalı, Zehra, et al.
Publicado: (2016)

Response to three years of growth hormone therapy in girls with Turner syndrome
por: Park, Hong Kyu, et al.
Publicado: (2013)

Favorable Impact of Growth Hormone Treatment on Cholesterol Levels in Turner Syndrome
por: Kohno, Hitoshi, et al.
Publicado: (2012)

Growth Hormone Treatment in Turner's Syndrome: A Real World Experience
por: Reddy Danda, Vijay Sheker, et al.
Publicado: (2017)

Implications of a Data-Driven Approach to Treatment with Growth Hormone in Children with Growth Hormone Deficiency and Turner Syndrome
por: Kaspers, Stefan, et al.
Publicado: (2013)

A case series of intracranial hypertension in patients with Turner syndrome, with and without growth hormone therapy
por: Pascoe, Emily, et al.
Publicado: (2015)

Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up
por: Laine, C. M., et al.
Publicado: (2017)

Hypertrophic scars in a patient with Turner's syndrome treated with recombinant growth hormone
por: Kędzia, Andrzej, et al.
Publicado: (2014)

Factors predicting the response to growth hormone therapy in Taiwanese patients with Turner syndrome
por: Huang, Ying-Hua, et al.
Publicado: (2013)

Childhood growth hormone treatment in women with Turner syndrome - benefits and adverse effects
por: Irzyniec, Tomasz, et al.
Publicado: (2019)

Metabolic consequences of recombinant human growth hormone therapy in patients with Turner syndrome
por: Gnacińska, Maria, et al.
Publicado: (2022)

Bone age is the best predictor of growth response to recombinant human growth hormone in Turner’s syndrome
por: Ismail, Nagwa Abdallah, et al.
Publicado: (2010)

Adrenarche and pubarche in girls with turner syndrome during growth-promoting therapy with human growth hormone
por: Dörr, Helmuth G., et al.
Publicado: (2019)

Normalization of puberty and adult height in girls with Turner syndrome: results of the Swedish Growth Hormone trials initiating transition into adulthood
por: Kriström, Berit, et al.
Publicado: (2023)

Growth in girls with Turner syndrome
por: Isojima, Tsuyoshi, et al.
Publicado: (2023)

Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review
por: Reh, Christina Southern, et al.
Publicado: (2010)

No late effects of growth hormone exposure on ventricular mass and function in patients with Turner's syndrome
por: Panayotova, Rosica, et al.
Publicado: (2013)

Karyotype Abnormalities in the X Chromosome Predict Response to the Growth Hormone Therapy in Turner Syndrome
por: Kasprzyk, Jakub, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0km7hkt10vloerq7g8jamule6c